多替阿巴拉米片什么时候吃？

It has recently been launched in China. This doptabalamid tablet is well tolerated, has a high resistance barrier, and has minimal drug interactions. One tablet a day, one tablet at a time, greatly reduces the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life. AIDS is gradually becoming a controllable and controllable chronic disease, such as hypertension and diabetes.

For adults and adolescents (with a body weight of at least 40 kg), the recommended dose of Dolutegra is one tablet, once daily. Adults or adolescents whose body weight is less than 40 kg should not be given dolutea as dolutea is a fixed-dose tablet and cannot be reduced.

Dolutegravir is a fixed-dose tablet and should not be used in patients requiring dose adjustments. If discontinuation or dose adjustment of one of the active ingredients is required, separate formulations of dolutegravir, abacavir, or lamivudine may be used. In these circumstances, physicians should refer to the respective product information for these medicines.

If the patient misses a dose of Docetaxel, and it is more than 4 hours before the next dose, Docetaxel should be taken as soon as possible. If the next dose is less than 4 hours away, patients should not take the missed dose and simply resume their usual dosing schedule.

It is the only three-in-one compound drug containing dolutegravir (DTG), which integrates treatment drugs for different stages of viral infection in the same pill. Patients only need to take one drug to achieve the effect of combined medication. The drug has been approved for marketing in 50 countries and regions, and has been recommended by many authoritative academic institutions and authoritative guidelines in Europe and the United States as the first-line first-line treatment for patients with HIV infection.